Health professionals wonder about future of COVID drugs as federal funding wanes

Jun 29, 2022
Drugmaker Eli Lilly will supply the government with another 150,000 doses of its monoclonal antibody to meet short-term demand.
A free monoclonal antibody treatment site in Miami. Eli Lilly said it will provide more of its antibody medication to the government, but drugmakers may shift their sales to the commercial market.
Joe Raedle/Getty Images

U.S. and EU vaccine deals raise fears of 'vaccine nationalism'

Jul 31, 2020
What does it mean for the rest of the world if countries have dibs on vaccine doses?
President Donald Trump tours a North Carolina lab making components for a potential vaccine. The U.S. has struck deals with drug companies for access to coronavirus vaccines in development.
Jim Watson/AFP via Getty Images